Circulating Levels of TNF Receptor II Are Prognostic for Patients With Peripheral T-Cell Non-Hodgkin Lymphoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-3299
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Prognostic Markers in Peripheral T-Cell Lymphoma

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2010English

Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T-Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2014English

The Prognostic Significance of Elevated Levels of Serum Ferritin Before Chemotherapy in Patients With Non-Hodgkin Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Comorbidity as an Independent Prognostic Factor in Elderly Patients With Peripheral T-Cell Lymphoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Management of Patients With Non-Hodgkin’s Lymphoma: Focus on Adoptive T-Cell Therapy

ImmunoTargets and Therapy
AllergyImmunology
2015English

Prognostic Factors in HIV-positive Patients With Non-Hodgkin Lymphoma: A Peruvian Experience

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2018English

Autologous Peripheral Blood Stem Cell Transplantation in Children and Adolescents With Non‑Hodgkin Lymphoma

Oncology Letters
Cancer ResearchOncology
2015English

Anti-Cd19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy